C. Camacho-Camacho et al. / Journal of Organometallic Chemistry 695 (2010) 833–840
839
4.2.3. [Bis(3,5-di-tert-butyl-2-hydroxy-2-
phenyl)amine]dichlorophenylstannate (2)
tBu quartet: 34.6 and 29.6, tBu CH3: 35.5 and 31.7, Sn–nBu: 29.8,
28.0, 20.4, 13.9 N–nBu 60.0, 31.7, 24.7, 13.6. Mass – TOF found
726.2856 calc. for C36H58NO2SnCl2 726.2867. Anal. calc. for
C36H59ClO2NSn: C, 62.48; H, 8.59; N, 2.02. Found: C, 62.50; H,
8.39; N, 1.96.
4.2.3.1. Method A. To a solution of 3,5-di-tert-butylcatechol (1.11 g,
5 mmol) in 15 mL of ethanol at 0 °C of conc. aqueous ammonia
(3 mL) was added followed by SnPhCl3 (755 mg, 2.5 mmol) in
10 mL of ethanol. After 2 h at 0 °C, the reaction was continued at
room temperature for 48 h. The reaction mixture was filtered
and the solid washed with water and ethanol and dried. The solid
was dissolved in CH2Cl2 and filtered. The solution was evaporated
under vacuum. Dark green crystals were obtained that were
recrystallized from CH2Cl2 : ethanol (360 mg, 21%).
4.2.7. [Bis(3,5-di-tert-butyl-2-hydroxy-2-phenyl)amine]n-butyl-
dichlorostannate (7)
A solution of compound 3 (300 mg, 0.33 mmol) and SnCl3nBu
(0.11 mL, 0.66 mmol) in 15 ml of toluene was refluxed for 3 h
and the solvent was evaporated under vacuum. A violet solid
was obtained (260 mg, 59%). The 119Sn spectrum of the reaction
product showed a main signal for compound 7 (d = À311 90%),
and 5% of compound 4. The -TOF mass spectrum showed a main
peak at 704.1866, calc 704.1851 for C32H49NO2SnCl3 which corre-
sponds to compound 7 plus a chlorine atom. Mp 130–137 °C.
NMR (CDCl3, ppm), 1H d = H3 7.37, H5 7.27, tBu: 1.44, 1.32, nBu
3.55, 2.37, 1.26 0.87. 13C d = C1 174.1, C2 132.5, C3 116.9, C4
141.7, C5 138.6, C6 149.7, tBu quater 35.6, 34.8, tBu CH3 31.7,
29.7, nBu 29.4, 28.2, 20.3 13.9.
4.2.3.2. Method B. A solution of compound 3 (300 mg, 0.33 mmol)
and SnPh2Cl2 (227 mg, 0.66 mmol) or SnPhCl3 (254 mg, 0.66 mmol)
in 10 mL of toluene was heated at 100 °C. After 3 h, the solvent was
evaporated under vacuum. The solid was washed with water and
the main product extracted with CH2Cl2. The solvent was evapo-
rated and the crystalline product was recrystallized from [1:1]
CH2Cl2:hexane (340 mg, 75%).
Mp 216–218 °C. NMR (CDCl3, ppm), 119Sn d = À427, 1H d = H3
7.56, H5 7.50, tBu: 1.39, 1.33, Ph: Ho and Hp 8.20, Hm 7.67. 13C
d = C1 174.3, C2 135.0 [83 Hz], C3 116.2 [49.5 Hz], C4 145.2
[26 Hz], C5 138.9, C6 149.8, tBu quater 35.8, 35.5, tBu CH3 30.0,
29.2, Ph: Ci 144.5, Co 133.8 [86 Hz], Cm 128.8 [138 Hz], Cp 130.4
[28 Hz]. Mass – TOF found 689.1858 calculated for C34H45NO2SnCl2
689.1849. Anal. calc. for C34H45Cl2NO2Sn: C, 59.24; H, 6.58; N, 2.03.
Found: C, 59.43; H, 6.82; N, 1.96.
Acknowledgments
Financial support from Cinvestav and Conacyt-Mexico is
acknowledged. The authors are grateful to J. Guthrie for valuable
comments and discussions.
Appendix A. Supplementary material
4.2.4. [Bis(3,5-di-tert-butyl-2-hydroxy-2-phenyl)amine]trichloro-
stannate (4)
CCDC 711032, 711033. 711034 and 711035 contain the supple-
mentary crystallographic data for compounds 1, 2, 5 and 3 respec-
tively. These data can be obtained free of charge from The
Compound 3 (0.3 g, 0.33 mmol) and SnCl4 (0.1 mL, 0.45 mmol)
in 10 mL of toluene were heated at 90 °C. After 3 h, the solvent
was evaporated under vacuum. The solid product was washed with
water and the main product extracted with CH2Cl2. The solvent
was evaporated in vacuum and the product recrystallized from
[1:1] CH2Cl2:hexane (200 mg, 65%). Mp 222–224 C. NMR (CDCl3,
ppm), 119Sn d = À514, 1H d = H3 7.65, H5 7.44, H9 1.45, H10 1.34.
13C d = C1 174.1, C2 133.1, C3 115.4, C4 145.4, C5 140.4, C6
151.1, tBu quater 35.9, 35.6, tBu CH3 29.6, 29.2. Mass – TOF found
647.1138, calc for C28H40NO2SnCl3 647.1147. Anal. Calc. for
C28H40NO2SnCl3: C, 51.93; H, 6.23; N, 2.16. Found: C, 51.62; H,
5.92; N, 2.44.
References
[1] R. Contreras, V.M. Jiménez-Pérez, C. Camacho-Camacho, M. Güizado-
Rodríguez, B. Wrackmeyer, J. Organomet. Chem. 604 (2000) 229.
[2] V.M. Jiménez-Pérez, C. Camacho-Camacho, M. Güizado-Rodríguez, H. Nöth, R.
Contreras, J. Organomet. Chem. 614/615 (2000) 283.
[3] V.M. Jiménez-Pérez, H. Nöth, A. Ariza-Castolo, A. Flores-Parra, R. Contreras, J.
Organomet. Chem. 691 (2006) 1584.
[4] C. Camacho-Camacho, H. Tlahuext, H. Nöth, R. Contreras, Heteroat. Chem. 9
(1998) 321.
4.2.5. [Bis(3,5-di-tert-butyl-2-hydroxy-2-phenyl)methylamine]chloro-
methyltin (5)
A solution of compound 3 (300 mg, 0.33 mmol) and SnMe2Cl2
(145 mg, 0.66 mmol) in 10 ml of toluene was refluxed for 3 h.
The solvent was then evaporated under vacuum. The solid was ex-
tracted with hexane, filtered and the solvent evaporated. Com-
pound 5 was crystallized from [1:1] CH2Cl2:hexane (140 mg,
49%). Mp 250–252 °C. NMR (CDCl3, ppm), 119Sn d = À165. 1H
d = H3 7.35, H5 7.23, tBu: 1.46, 1,34, CH3 1.93. 13C d = C1 150.8,
C2 135.2 [35.1 Hz], C3 116.6 [10.9 Hz], C4 140.8, C5 122.9, C6
138.6 [39.5 Hz], C7 31.8.6, C8 29.7, C9 35.7, C10 34.7, Sn-CH3
30.0. N–CH3 56.5. Anal. calc. for C30H47ClO2NSn: C, 59.28; H,
7.79; N, 2.30. Found: C, 59.38; H, 7.64; N, 2.31.
[5] C. Camacho-Camacho, A. Esparza-Ruiz, A. Vásquez-Badillo, H. Nöth, A. Flores-
Parra, R. Contreras, J. Organomet. Chem. 694 (2009) 726.
[6] B.H. Keppler, Metal Complexes in Cancer Chemotherapy, VCH, Weinheim,
1993;
M. Gielen, Tin Based Anti-tumor Drugs, Springer-Verlag, Berlin, 1990.
[7] V.L. Narayanan, M. Nasr, K.O. Paull (Eds.), Tin Based Antitumour DrugsM.
Gielen (Ed.), NATO ASI Series, 200–217, Springer-Verlag, Berlin, 1990, p. 69.
[8] A.G. Davies, P.J. Smith, in: G. Wilkinson (Ed.), Comprehensive Organometallic
Chemistry, Pergamon Press, New York, 1982, p. 519.
[9] M. Gielen, Appl. Organomet. Chem. 16 (2002) 481.
[10] M. Gielen, M. Biesemans, R. Willem, Appl. Organomet. Chem. 19 (2005) 440.
[11] M. Gielen, J. Braz. Chem. Soc. 14 (2003) 870.
[12] M. Sabanero, E. Rojas, V. Torres, N. Farfán, A. Flores, R. Contreras, Microbios 82
(1995) 173.
[13] R. Contreras, A. Murillo, G. Uribe, A. Klaébé, Heterocycles 23 (1985) 2187.
[14] N. Farfán, P. Joseph-Nathan, L.M. Chiquete, R. Contreras, J. Organomet. Chem.
348 (1988) 149.
4.2.6. [Bis(3,5-di-tert-butyl-2-hydroxy-2-phenyl)butylamine]n-butyl-
chlorotin (6)
[15] R. Contreras, A. Murillo, P. Joseph-Nathan, Phosphorus, Sulfur Silicon Relat.
Elem. 47 (1990) 215.
[16] A. Murillo, L.M. Chiquete, P. Joseph-Nathan, R. Contreras, Phosphorus, Sulfur
Silicon Relat. Elem. 53 (1990) 87.
The same procedure as for compound 5, was followed using
compound
3
(300 mg, 0.33 mmol) and SnBu2Cl2 (200 mg,
0.66 mmol) in 10 mL of toluene. Dark violet crystals were obtained
(200 mg, 44%). Mp 129–131 °C. NMR (CDCl3), 119Sn d = À186; 1H
d = H3 7.37, H5 7.24, tBu: 1.46, 1.34, Sn-nBu CH3 0.84 [14.64]:
N–nBu CH2 3.36, 1.47, 1.45, CH3 0.93. 13C d = C1 151.6 [32] C2
137.4 [34.5], C3 116.9 [8.5] C4 140.0 C5 122.5 C6 138.6 [38.5],
[17] C. Camacho-Camacho, F.J. Martínez-Martínez, M.J. Rosales-Hoz, R. Contreras,
Phosphorus, Sulfur Silicon Relat. Elem. 91 (1994) 189.
[18] C. Camacho-Camacho, G. Merino, F.J. Martínez-Martínez, H. Nöth, R. Contreras,
Eur. J. Inorg. Chem. (1999) 1021.
[19] C.L. Frye, G.A. Vincent, G.L. Hauschildt, J. Am. Chem. Soc. 88 (1966) 2727.
[20] C.G. Pierpont, S.K. Larsen, S.R. Boone, Pure Appl. Chem. 60 (1988) 1331.